Armstrong Fleming & Moore’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
+5,306
| New | +$366K | 0.2% | 69 |
|
|
2025
Q1 | – | Sell |
-5,924
| Closed | -$510K | – | 135 |
|
|
2024
Q4 | $510K | Sell |
5,924
-1,608
| -21% | -$138K | 0.31% | 55 |
|
|
2024
Q3 | $897K | Buy |
7,532
+500
| +7% | +$59.5K | 0.52% | 38 |
|
|
2024
Q2 | $1M | Buy |
7,032
+2,374
| +51% | +$339K | 0.64% | 28 |
|
|
2024
Q1 | $598K | Hold |
4,658
| – | – | 0.41% | 46 |
|
|
2023
Q4 | $482K | Hold |
4,658
| – | – | 0.36% | 54 |
|
|
2023
Q3 | $424K | Buy |
4,658
+330
| +8% | +$30K | 0.41% | 54 |
|
|
2023
Q2 | $350K | Buy |
+4,328
| New | +$350K | 0.32% | 63 |
|